Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-19-000113
Filing Date
2019-01-29
Accepted
2019-01-29 20:43:51
Documents
1
Period of Report
2019-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5835
  Complete submission text file 0000904454-19-000113.txt   7197
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNIQUIRE N.V. 113 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Springhorn Jeremy P. (Reporting) CIK: 0001717852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 19550134